Abstract Details
|
Olivia Kingsford, DO
PRESENTER |
Dr. Kingsford has nothing to disclose. |
| Harjot Hansra, MD (Dignity Health/Barrow Neurological Institute) | Dr. Hansra has nothing to disclose. |
| Judea Wiggins, MD (Barrow Neurological Institute) | Dr. Wiggins has nothing to disclose. |
| Jonathan Bryant, MD | Dr. Bryant has nothing to disclose. |
| Bryan Franzen, DO | Dr. Franzen has nothing to disclose. |
| Jay Patel, MD | Dr. Patel has nothing to disclose. |
| Laura Greenwood, DO (Barrow Neurological Insititute) | Dr. Greenwood has nothing to disclose. |
| Michael V. Robers, MD (Barrow Neurological Institute) | Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Genentech. Dr. Robers has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for TG therapeutics. Dr. Robers has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Sanofi. Dr. Robers has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for TG Therapeutics. The institution of Dr. Robers has received research support from Bristol Myers Squibb Foundation. |